Hypoparathyroidism leads to decreased calcium ... short-term therapy with vitamin D and calcium supplementation. "The ability to address the underlying cause of this disease is crucial and will ...
Expert Rev Endocrinol Metab. 2012;7(3):255-257. The future of hormone replacement therapy in hypoparathyroidism can be viewed with optimism, even if we are left with several unanswered questions ...
The majority of adults with hypoparathyroidism achieved normal serum calcium levels with palopegteriparatide at 1 year without supplemental vitamin D or calcium, according to data from a phase 3 ...
YORVIPATH (palopegteriparatide) is indicated for the treatment of hypoparathyroidism in adults ... least 7.8 mg/dL using calcium and active vitamin D treatment. YORVIPATH is contraindicated ...
YORVIPATH was not studied for acute post-surgical hypoparathyroidism ... calcium of at least 7.8 mg/dL using calcium and active vitamin D treatment. YORVIPATH is contraindicated in patients ...